Core Viewpoint - The Beachbody Company, Inc. (BODI) shows potential for significant upside, with a mean price target of $10.75 indicating an 82.5% increase from its current price of $5.89 [1] Price Targets and Estimates - The mean estimate consists of four short-term price targets with a standard deviation of $3.88, suggesting variability among analysts [2] - The lowest estimate of $6.50 indicates a 10.4% increase, while the highest estimate of $15.50 suggests a potential surge of 163.2% [2] - A low standard deviation indicates a strong agreement among analysts regarding the stock's price movement [9] Analyst Sentiment and Earnings Estimates - Analysts show growing optimism about BODI's earnings prospects, as indicated by a positive trend in earnings estimate revisions [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 20.3%, with one estimate moving higher and no negative revisions [12] - BODI holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - While price targets are often sought after, they can mislead investors, and reliance solely on them may lead to poor investment decisions [3][7][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]

Helios Technologies (HLIO) closed the last trading session at $53.12, gaining 7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $67.33 indicates a 26.8% upside potential.The mean estimate comprises three short-term price targets with a standard deviation of $4.93. While the lowest estimate of $64.00 indicates a 20.5% increase from the current price level, the most optimistic analy ...

Core Viewpoint - Vista Energy, S.A.B. de C.V. (VIST) has shown a significant price increase of 28.7% over the past four weeks, with a mean price target of $62.09 indicating a potential upside of 26.5% from the current price of $49.1 [1] Price Targets and Analyst Estimates - The mean estimate for VIST comprises seven short-term price targets with a standard deviation of $7.36, suggesting variability in analyst predictions. The lowest estimate is $50.00 (1.8% increase), while the highest is $70.00 (42.6% increase) [2] - A low standard deviation among price targets indicates a high degree of agreement among analysts regarding the stock's price movement direction, which can serve as a starting point for further research [9] Earnings Estimates and Analyst Sentiment - Analysts have shown increasing optimism about VIST's earnings prospects, as evidenced by a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 7.7%, with one estimate moving higher and no negative revisions [12] - VIST holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for near-term upside [13] Caution on Price Targets - While the consensus price target is a commonly referenced metric, relying solely on it for investment decisions may not be prudent due to historical inaccuracies in analyst predictions [3][7][10] - Analysts often set optimistic price targets influenced by business relationships, which can lead to inflated expectations [8]

Core Viewpoint - Omnicell (OMCL) has shown a significant price increase of 20.1% over the past four weeks, with a mean price target of $48 indicating a potential upside of 34.5% from its current price of $35.68 [1] Price Targets and Analyst Consensus - The average price target for OMCL ranges from a low of $36.00 to a high of $63.00, with a standard deviation of $10.34, indicating variability in analyst estimates [2] - The lowest estimate suggests a modest increase of 0.9%, while the highest estimate indicates a substantial upside of 76.6% [2] - A low standard deviation signifies a strong agreement among analysts regarding the stock's price movement direction [9] Earnings Estimates and Analyst Optimism - Analysts have shown growing optimism regarding OMCL's earnings prospects, as evidenced by a positive trend in earnings estimate revisions [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 8.8%, with two estimates moving higher and no negative revisions [12] - OMCL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - While price targets are often sought after by investors, they can be misleading and should not be the sole basis for investment decisions [3][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]

Shares of Chime Financial, Inc. (CHYM) have gained 3.9% over the past four weeks to close the last trading session at $20.34, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $30.93 indicates a potential upside of 52.1%.The mean estimate comprises 15 short-term price targets with a standard deviation of $8.02. While the lowest estimate of $17.00 indicates a 16.4% decline from the ...

Core Viewpoint - Pharming Group N.V. (PHAR) shares have increased by 8.1% in the past four weeks, closing at $15.43, with a potential upside of 100.9% based on Wall Street analysts' mean price target of $31 [1][11]. Price Targets and Analyst Estimates - The mean price target consists of three short-term estimates with a standard deviation of $14.93, indicating variability among analysts. The lowest estimate is $14.00 (9.3% decline), while the highest is $42.00 (172.2% increase) [2][9]. - Analysts' price targets can often mislead investors, as empirical research shows they rarely indicate actual stock price movements [7][10]. - A low standard deviation in price targets suggests a strong agreement among analysts regarding the stock's price direction, which can be a starting point for further research [9]. Earnings Estimates and Analyst Sentiment - There is growing optimism among analysts regarding PHAR's earnings prospects, supported by a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [11][12]. - Over the last 30 days, one estimate has increased, leading to a 220% rise in the Zacks Consensus Estimate for the current year [12]. - PHAR holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13]. Conclusion on Price Movement - While the consensus price target may not be a reliable measure of potential gains, the implied direction of price movement appears to be a useful guide for investors [14].

Group 1 - PRA Group (PRAA) shares have increased by 10.1% over the past four weeks, closing at $14.75, with a mean price target of $22.67 indicating a potential upside of 53.7% [1] - The mean estimate includes three short-term price targets with a standard deviation of $4.16, where the lowest estimate of $18.00 suggests a 22% increase, and the highest estimate of $26.00 indicates a 76.3% surge [2] - Analysts show strong agreement on PRAA's ability to report better earnings, with a positive trend in earnings estimate revisions correlating with potential stock price increases [4][11] Group 2 - Over the last 30 days, the Zacks Consensus Estimate for PRAA's current year earnings has risen by 10.3%, with two estimates moving higher and no negative revisions [12] - PRAA holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside [13] - While consensus price targets may not be entirely reliable, the direction they imply appears to be a good guide for potential price movement [14]

Core Viewpoint - SkyWest (SKYW) shows potential for significant upside, with a mean price target of $133.6 indicating a 35.5% increase from the current price of $98.6 [1] Price Targets - The average price target consists of five estimates ranging from a low of $126.00 to a high of $150.00, with a standard deviation of $9.42, suggesting a consensus among analysts [2] - The lowest estimate indicates a 27.8% increase, while the highest suggests a 52.1% upside [2] Analyst Sentiment - Analysts have shown increasing optimism regarding SkyWest's earnings prospects, as evidenced by a strong agreement in revising EPS estimates higher [11] - Over the last 30 days, three estimates have been revised upward, leading to a 3.9% increase in the Zacks Consensus Estimate [12] Zacks Rank - SkyWest currently holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors [13] Conclusion on Price Movement - While the consensus price target may not be a reliable indicator of the extent of potential gains, it does provide a useful guide for the direction of price movement [14]

Core Viewpoint - Tree.com (TREE) shares have increased by 5.1% in the last four weeks, closing at $62.02, with a potential upside of 31.1% based on Wall Street analysts' mean price target of $81.33 [1][11]. Price Targets - The average price target consists of six estimates ranging from a low of $72.00 to a high of $85.00, with a standard deviation of $4.93, indicating a relatively tight clustering of estimates [2][9]. - The lowest estimate suggests a 16.1% increase from the current price, while the highest indicates a 37.1% upside [2]. Analyst Sentiment - Analysts show strong agreement in revising earnings estimates higher, which historically correlates with stock price movements [4][11]. - The Zacks Consensus Estimate for the current year has risen by 29.7% over the past month, with three estimates increasing and no negative revisions [12]. Zacks Rank - TREE holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, suggesting a strong potential upside [13]. Caution on Price Targets - While price targets are commonly referenced, they can mislead investors, as empirical research indicates they rarely predict actual stock price movements accurately [7][10]. - Analysts may set optimistic price targets due to business incentives, which can inflate expectations [8][9].

Core Viewpoint - Kamada (KMDA) shares have shown a 1.2% increase over the past four weeks, closing at $6.92, with a potential upside indicated by Wall Street analysts' price targets suggesting a mean estimate of $14.75, representing a 113.2% upside [1] Price Targets - The average price targets from analysts range from a low of $11.00 to a high of $20.00, with a standard deviation of $3.86, indicating a potential increase of 59% to 189% from the current price level [2] - A low standard deviation suggests a greater agreement among analysts regarding the price targets, which can be a useful indicator for further research [2][9] Analyst Sentiment - Analysts have shown increasing optimism regarding Kamada's earnings prospects, with a strong consensus in revising EPS estimates higher, which correlates with potential stock price movements [4][11] - Over the last 30 days, one estimate has increased while there were no negative revisions, leading to a 4.4% increase in the Zacks Consensus Estimate for the current year [12] Zacks Rank - Kamada currently holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential upside in the near term [13] Conclusion on Price Targets - While the consensus price target may not be a reliable measure of the extent of potential gains, it does provide a directional guide for price movement [14]